152 related articles for article (PubMed ID: 28194882)
21. Treatments to prevent primary venous ulceration after deep venous thrombosis.
Doliner B; Jaller JA; Lopez AJ; Lev-Tov H
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):260-271.e1. PubMed ID: 30660582
[TBL] [Abstract][Full Text] [Related]
22. Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
Brener SJ
Cleve Clin J Med; 2000 Jan; 67(1):59-65. PubMed ID: 10645678
[TBL] [Abstract][Full Text] [Related]
23. Low-molecular weight heparins - the mainstay of anti-coagulant therapy.
Cardiovasc J S Afr; 2002; 13(2):80-2. PubMed ID: 12166360
[No Abstract] [Full Text] [Related]
24. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
25. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
Lin PT; Wang SH; Chi CC
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
[TBL] [Abstract][Full Text] [Related]
26. Low-molecular-weight heparin: more indications for use.
Kujovich JL
Hosp Pract (1995); 1999 Apr; 34(4):67-8, 71-8, 83; discussion 83-4. PubMed ID: 10212632
[TBL] [Abstract][Full Text] [Related]
27. Importance of meta-analysis of long-term trials of low-molecular-weight heparin vs vitamin K antagonist in pulmonary embolism.
Koracevic GP
Am J Emerg Med; 2013 Mar; 31(3):627-8. PubMed ID: 23337178
[No Abstract] [Full Text] [Related]
28. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
29. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
Potdar N; Gelbaya TA; Konje JC; Nardo LG
Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
[TBL] [Abstract][Full Text] [Related]
30. Randomised evaluation of treatment modalities in thromboembolic disorders.
ten Cate JW; Büller HR
Haematologica; 1999 Jun; 84 Suppl EHA-4():85-7. PubMed ID: 10907478
[No Abstract] [Full Text] [Related]
31. Prevention of venous thromboembolism after acute ischaemic stroke.
Ricci S; Celani MG; Righetti E; Dennis M; Sandercock P
Lancet; 2007 Sep; 370(9589):735-6; author reply 736-7. PubMed ID: 17765511
[No Abstract] [Full Text] [Related]
32. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
Brewer D
Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
[No Abstract] [Full Text] [Related]
33. Summaries for patients. Low-molecular-weight heparin given for several weeks after hip surgery prevents deep venous thrombosis.
Ann Intern Med; 2001 Nov; 135(10):S-55. PubMed ID: 11757493
[No Abstract] [Full Text] [Related]
34. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
Lu C; Liu Y; Jiang HL
J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
36. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
37. The status of new anticoagulants.
Bates SM; Weitz JI
Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
[TBL] [Abstract][Full Text] [Related]
38. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
39. The optimal long-term treatment of venous thromboembolism.
Prandoni P
Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
[No Abstract] [Full Text] [Related]
40. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
Ageno W; Squizzato A
Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
